+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Summit Therapeutics plc - logo

Summit Therapeutics is a biopharmaceutical company focussed on the development of novel medicines to treat the fatal muscle wasting disease Duchenne muscular dystrophy and infections caused by the bacteria C. difficile. The company is developing Ezutromid, an utrophin modulator product candidate that is in Phase II clinical trials used for to treat Duchenne muscular dystrophy disease. Summit Therapeutics plc was founded in 2003 and is based in Abingdon, the United Kingdom.

Clostridioides difficile Associated Enteropathy (Clostridium difficile Associated Enteropathy) - Pipeline Review, H2 2020 - Product Thumbnail Image

Clostridioides difficile Associated Enteropathy (Clostridium difficile Associated Enteropathy) - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 278 Pages
  • Global
From
Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Duchenne Muscular Dystrophy - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • November 2021
  • 223 Pages
  • Global
From
Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2020 - Product Thumbnail Image

Clostridioides difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H1 2020

  • Drug Pipelines
  • April 2020
  • 267 Pages
  • Global
From
Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2019 - Product Thumbnail Image

Clostridium difficile Infections (Clostridium difficile Associated Disease) - Pipeline Review, H2 2019

  • Drug Pipelines
  • December 2019
  • 255 Pages
  • Global
From
Pseudomonas aeruginosa Infections - Pipeline Review, H2 2019 - Product Thumbnail Image

Pseudomonas aeruginosa Infections - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 282 Pages
  • Global
From
Sepsis - Pipeline Review, H2 2019 - Product Thumbnail Image

Sepsis - Pipeline Review, H2 2019

  • Drug Pipelines
  • November 2019
  • 367 Pages
  • Global
From
Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020 - Product Thumbnail Image

Duchenne Muscular Dystrophy Disease - Global Clinical Trials Review, H2, 2020

  • Clinical Trials
  • October 2020
  • 211 Pages
  • Global
From
China Pharmaceutical Companies and Drugs Pipeline Insight 2023 - Product Thumbnail Image

China Pharmaceutical Companies and Drugs Pipeline Insight 2023

  • Drug Pipelines
  • September 2023
  • 2800 Pages
  • China
From
2021 Analytics of the Microbiome Landscape - Product Thumbnail Image

2021 Analytics of the Microbiome Landscape

  • Report
  • April 2021
  • 26 Pages
  • Global
From
Gonorrhoea - Pipeline Insight, 2024 - Product Thumbnail Image

Gonorrhoea - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024 - Product Thumbnail Image

PD-1 and PD-L1 Inhibitors - Competitive Landscape, 2024

  • Report
  • February 2024
  • 450 Pages
  • Global
From
Bispecific antibody - Competitive landscape, 2023 - Product Thumbnail Image

Bispecific antibody - Competitive landscape, 2023

  • Report
  • May 2023
  • 450 Pages
  • Global
From
Ridinilazole Emerging Drug Insight and Market Forecast - 2032 - Product Thumbnail Image

Ridinilazole Emerging Drug Insight and Market Forecast - 2032

  • Report
  • November 2023
  • 30 Pages
  • Global
From
Comprehensive Report on Summit Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas - Product Thumbnail Image

Comprehensive Report on Summit Therapeutics Inc, including SWOT, PESTLE and Business Model Canvas

  • SWOT Analysis
  • August 2023
  • 90 Pages
From
Loading Indicator